Antibe Therapeutics Inc.

ATBPF · OTC
Analyze with AI
12/31/2023
9/30/2023
6/30/2023
3/31/2023
Assets
Cash & Equivalents$11,339$4,143$8,793$6,755
Short-Term Investments$13,567$23,733$25,514$32,137
Receivables$1,504$1,595$1,500$1,615
Inventory$0$44$44$40
Other Curr. Assets$1,685$1,628$1,970$1,039
Total Curr. Assets$28,095$31,099$37,777$41,546
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$26,326$26,326$0
Intangibles$26,352$26$26$26,352
Long-Term Investments$0$1,471$1,425$1,380
Tax Assets$0$0$0$0
Other NC Assets$1,915$1,283$1,283$1,283
Total NC Assets$28,267$29,106$29,060$29,015
Other Assets$0$0$0$0
Total Assets$56,362$60,205$66,837$70,561
Liabilities
Payables$3$0$0$0
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,791$2,862$4,406$2,761
Total Curr. Liab.$2,794$2,865$4,410$2,764
LT Debt$0$0$0$0
Deferred Rev, NC$27,631$27,631$27,631$27,631
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$27,631$27,631$27,631$27,631
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$30,425$30,496$32,041$30,395
Equity
Pref Stock$0$0$0$0
Common Stock$141,607$141,582$141,581$141,489
Retained Earnings-$145,498-$141,285-$136,277-$130,491
AOCI$0$10,264$10,264$10,264
Other Equity$29,828$19,148$19,228$18,904
Total Equity$25,937$29,709$34,796$40,166
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$56,362$60,205$66,837$70,561
Net Debt-$11,339-$4,143-$8,793-$6,755